Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.75 [0.53-1.05],0.095237819784875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD302,CD302 antigen,Inverse variance weighted,17,0.94 [0.79-1.13],0.537379392226914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAYN,Layilin,Inverse variance weighted,23,1.01 [0.83-1.23],0.907579526864683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,8,1.26 [0.94-1.68],0.117698950788288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,16,0.94 [0.74-1.20],0.628380644454166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,15,0.99 [0.73-1.34],0.953292302476646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRELP,Prolargin,Inverse variance weighted,14,1.02 [0.85-1.23],0.809722154343292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,1.39 [0.81-2.40],0.235883269862113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDF15,Growth/differentiation factor 15,Inverse variance weighted,14,1.06 [0.72-1.58],0.759285725052342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,17,1.14 [0.91-1.42],0.249621760536398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPY,Pro-neuropeptide Y,Inverse variance weighted,18,0.88 [0.67-1.14],0.325773811599432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD93,Complement component C1q receptor,Inverse variance weighted,2,0.86 [0.37-1.97],0.715272778093588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.97 [0.86-1.08],0.535080299575623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFD,Complement factor D,Inverse variance weighted,12,1.18 [0.90-1.55],0.218280868107711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.92 [0.54-1.59],0.772014267251788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,16,0.91 [0.75-1.11],0.365030349711943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,16,1.08 [0.92-1.27],0.333222508842636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HYAL1,Hyaluronidase-1,Inverse variance weighted,23,1.05 [0.91-1.23],0.500181259590817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFASC,Neurofascin,Inverse variance weighted,19,0.87 [0.75-1.02],0.0808725602340293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,75,0.95 [0.87-1.03],0.230099624025106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.11 [0.97-1.28],0.140165889229236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.22 [0.93-1.60],0.160341200610164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INHBB,Inhibin beta B chain,Inverse variance weighted,16,0.99 [0.67-1.47],0.949594203396029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA12,Carbonic anhydrase 12,Inverse variance weighted,20,0.94 [0.80-1.12],0.498662146882478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,31,0.98 [0.85-1.12],0.761626416829903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,0.93 [0.38-2.26],0.878099908255497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS8,Prostasin,Inverse variance weighted,19,1.08 [0.76-1.54],0.670074730821284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSTL3,Follistatin-related protein 3,Inverse variance weighted,7,0.74 [0.42-1.30],0.295325982059227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.00 [0.82-1.22],0.967982846543211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,8,0.86 [0.53-1.38],0.522720107393528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,35,1.05 [0.90-1.22],0.528730457032645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,30,1.03 [0.90-1.18],0.71168241658087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,2.21 [0.85-5.76],0.104140134127873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,34,1.03 [0.84-1.26],0.780481070938772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,0.97 [0.86-1.09],0.620553769572106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPT2,Angiopoietin-2,Inverse variance weighted,11,0.87 [0.67-1.13],0.304069585722249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,40,0.94 [0.85-1.04],0.200188385626952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,1.07 [0.60-1.92],0.826063422618676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM2,Paralemmin-2,Inverse variance weighted,9,1.49 [1.15-1.93],0.0025992836177299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1B,Lithostathine-1-beta,Inverse variance weighted,26,1.23 [1.06-1.42],0.0050067281213394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST3,Cystatin-C,Inverse variance weighted,13,1.11 [0.91-1.37],0.297383202752285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,17,1.09 [0.92-1.29],0.315525751271726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP7,Matrilysin,Inverse variance weighted,15,0.96 [0.74-1.24],0.744766186146254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,75,1.07 [0.99-1.15],0.0927860003358265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.41 [0.97-2.05],0.0707210111211147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,13,1.05 [0.75-1.49],0.767235903050861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.17 [0.56-2.44],0.676227688033894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,8,0.79 [0.64-0.96],0.0168424674436093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EBI3_IL27,Interleukin-27,Inverse variance weighted,37,1.03 [0.91-1.18],0.632933009322856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLMP,CXADR-like membrane protein,Inverse variance weighted,15,0.93 [0.79-1.11],0.420114360434447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHISA5,Protein shisa-5,Inverse variance weighted,16,1.23 [0.84-1.80],0.297379181892088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLL1,Delta-like protein 1,Inverse variance weighted,13,1.10 [0.84-1.46],0.482239123660296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN3,CCN family member 3,Inverse variance weighted,20,0.97 [0.81-1.18],0.780307701401114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,22,1.08 [0.93-1.25],0.339403476354933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSC2,Desmocollin-2,Inverse variance weighted,16,1.01 [0.83-1.22],0.944154667405273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,15,0.95 [0.69-1.29],0.728501193275396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.03 [0.62-1.71],0.91597927978753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,11,0.78 [0.44-1.40],0.409500097891407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA4,Apolipoprotein A-IV,Inverse variance weighted,5,0.78 [0.31-1.98],0.602880872327799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,4,1.08 [0.68-1.72],0.737512315038172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,22,0.95 [0.77-1.17],0.622803887287201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASET2,Ribonuclease T2,Inverse variance weighted,25,0.93 [0.81-1.07],0.331111951072831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,0.72 [0.53-0.98],0.0383004221688792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,6,1.40 [0.79-2.48],0.248142933168724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,19,1.01 [0.85-1.21],0.873593206694607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH3,Cadherin-3,Inverse variance weighted,12,0.95 [0.67-1.33],0.757283770745858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.42 [0.69-2.93],0.341913168430513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,10,1.13 [0.70-1.82],0.608876273333462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD160,CD160 antigen,Inverse variance weighted,36,1.02 [0.88-1.17],0.823951304124724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.75 [0.24-2.28],0.60763506667202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,18,0.94 [0.64-1.36],0.729054026477398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD27,CD27 antigen,Inverse variance weighted,18,1.14 [0.95-1.36],0.155610936850968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.91 [0.68-1.21],0.507571230714317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UMOD,Uromodulin,Inverse variance weighted,62,0.91 [0.83-1.00],0.0555056085324173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.47 [0.24-0.90],0.023378409024532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUCA2A,Guanylin,Inverse variance weighted,16,0.94 [0.73-1.19],0.592814561476827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.08 [0.94-1.24],0.294818820306888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CX3CL1,Fractalkine,Inverse variance weighted,23,1.08 [0.90-1.30],0.402797366918463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,0.67 [0.40-1.14],0.138986977188487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,36,1.00 [0.91-1.11],0.967963704536384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AREG,Amphiregulin,Inverse variance weighted,7,1.04 [0.63-1.74],0.865836402059564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSAP,Prosaposin,Inverse variance weighted,13,0.95 [0.76-1.17],0.610897217735153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,19,1.22 [0.93-1.62],0.156226875178531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN8,Septin-8,Inverse variance weighted,6,1.20 [0.83-1.74],0.328295143201603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,28,1.03 [0.94-1.14],0.495662551802452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD55,Complement decay-accelerating factor,Inverse variance weighted,27,1.23 [1.07-1.40],0.0024794802968883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,0.97 [0.86-1.10],0.627805736137778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.10 [0.96-1.26],0.179236214418804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COLEC12,Collectin-12,Inverse variance weighted,13,1.04 [0.80-1.35],0.776070420758387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,17,0.90 [0.65-1.25],0.53584931103461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C7,Complement component C7,Inverse variance weighted,60,1.07 [0.99-1.16],0.101492694176558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,66,0.95 [0.89-1.02],0.172573240937274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,14,1.09 [0.83-1.42],0.550032817040945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,22,1.21 [0.96-1.51],0.106042422588756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPB6,Heat shock protein beta-6,Inverse variance weighted,5,0.77 [0.40-1.51],0.449584201006554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,24,0.85 [0.72-1.01],0.060675968176381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,50,0.99 [0.91-1.09],0.877660928280743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGF,Placenta growth factor,Inverse variance weighted,8,0.61 [0.35-1.08],0.0897465720592923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PI3,Elafin,Inverse variance weighted,20,1.05 [0.88-1.26],0.582789975699336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK4,Dickkopf-related protein 4,Inverse variance weighted,18,1.18 [0.86-1.64],0.309912919531826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDK,Midkine,Inverse variance weighted,19,1.39 [1.02-1.89],0.0343267054088347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.63 [0.47-0.85],0.0027996107162359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,3,0.86 [0.28-2.67],0.797774379587163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.00 [0.93-1.09],0.941933961216293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS4,Galectin-4,Inverse variance weighted,19,0.89 [0.75-1.05],0.173827520342903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,24,0.89 [0.75-1.07],0.215354522129713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,42,1.02 [0.91-1.14],0.719597800077681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,9,1.13 [0.80-1.59],0.498267534824362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC1,Sialoadhesin,Inverse variance weighted,31,1.06 [0.90-1.26],0.477038803506189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWC2,Brorin,Inverse variance weighted,35,1.05 [0.91-1.22],0.498510076276017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,11,0.92 [0.65-1.29],0.610697312458311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD48,CD48 antigen,Inverse variance weighted,32,1.01 [0.89-1.14],0.902220471223392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGN,Mimecan,Inverse variance weighted,37,0.97 [0.85-1.11],0.683216139306848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,6,1.01 [0.77-1.32],0.960286184257173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,11,1.19 [0.70-2.01],0.522476644956496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCN,Decorin,Inverse variance weighted,3,0.75 [0.30-1.91],0.546104976852333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGB,Secretogranin-1,Inverse variance weighted,33,0.91 [0.78-1.06],0.207227354835442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,17,0.89 [0.75-1.06],0.192160724437357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADM,Pro-adrenomedullin,Inverse variance weighted,4,0.73 [0.52-1.04],0.0816065035455297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK11,Kallikrein-11,Inverse variance weighted,19,1.08 [0.95-1.23],0.235282387028403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.86 [0.80-4.35],0.150117197041838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDN1,Endothelin-1,Inverse variance weighted,3,1.32 [0.98-1.76],0.0659378385573852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,9,0.97 [0.82-1.15],0.714943687521549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,15,1.04 [0.84-1.30],0.713509376406301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.65 [0.22-1.92],0.439362751612021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,4,0.94 [0.39-2.29],0.892354434170724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,23,1.07 [0.96-1.19],0.208259728549545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.53 [0.68-3.46],0.307187129359105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,11,1.01 [0.79-1.28],0.943200261380843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN4,Nectin-4,Inverse variance weighted,12,0.94 [0.69-1.28],0.68092514751735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,14,0.98 [0.73-1.32],0.895150798614492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RSPO3,R-spondin-3,Inverse variance weighted,11,1.05 [0.79-1.41],0.721668389997218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKB,Creatine kinase B-type,Inverse variance weighted,11,1.44 [0.81-2.55],0.216384611740439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,6,0.97 [0.75-1.26],0.819509770782632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.93 [0.78-1.12],0.444564315287047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,9,1.32 [0.73-2.39],0.352609881567519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,30,1.06 [0.92-1.22],0.394538070721905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.03 [0.64-1.66],0.900292804794705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,19,1.23 [1.01-1.49],0.0414016335629342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,5,0.87 [0.42-1.82],0.711072917328346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,43,0.95 [0.87-1.04],0.264592055597588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,9,1.36 [0.79-2.32],0.263402668866107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,42,1.06 [0.93-1.22],0.372642231452977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,8,1.13 [0.69-1.85],0.633472261469667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH1,Cadherin-1,Inverse variance weighted,17,1.08 [0.85-1.37],0.529662749850605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GM2A,Ganglioside GM2 activator,Inverse variance weighted,26,0.92 [0.82-1.03],0.134956846931251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,17,1.01 [0.78-1.30],0.956624311369744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,13,1.07 [0.54-2.12],0.834946088315906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,22,1.13 [0.92-1.39],0.232276585550947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,18,0.77 [0.62-0.95],0.0152762056613412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,13,1.09 [0.75-1.58],0.661526423469921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD83,CD83 antigen,Inverse variance weighted,19,1.03 [0.78-1.35],0.846185376524173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON1,Spondin-1,Inverse variance weighted,25,1.01 [0.87-1.19],0.857071857489667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,28,0.97 [0.87-1.09],0.617949386104889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,13,1.09 [0.85-1.39],0.48620457673221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XG,Glycoprotein Xg,Inverse variance weighted,2,0.43 [0.14-1.29],0.133946467063554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,34,1.00 [0.90-1.12],0.937509444089896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,18,1.12 [0.94-1.34],0.215766731907114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,62,0.96 [0.88-1.05],0.39157057276619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE6,Ribonuclease K6,Inverse variance weighted,20,1.05 [0.89-1.25],0.562289260766832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,22,1.08 [0.95-1.22],0.230097762423216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,41,0.93 [0.79-1.08],0.331800680630567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,30,0.97 [0.83-1.13],0.67541700261878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,21,1.20 [0.91-1.59],0.187694333993055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,18,1.31 [0.94-1.81],0.109090507368626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS9,Galectin-9,Inverse variance weighted,39,0.95 [0.84-1.09],0.480835538279121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN4,CCN family member 4,Inverse variance weighted,40,0.97 [0.87-1.10],0.665485775453597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.00 [0.74-1.35],0.976269462756162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR1,Folate receptor alpha,Inverse variance weighted,10,0.76 [0.54-1.06],0.108617685365856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON2,Spondin-2,Inverse variance weighted,8,1.26 [0.98-1.61],0.0735872947003248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.03 [0.82-1.29],0.822586504445692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.22 [0.98-1.52],0.075280685981482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,29,1.03 [0.91-1.17],0.632822234048631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA4,Ephrin-A4,Inverse variance weighted,5,0.65 [0.38-1.12],0.12295021953731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,20,0.89 [0.72-1.09],0.248292944337924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,27,0.98 [0.82-1.17],0.852632126918557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BSG,Basigin,Inverse variance weighted,8,1.13 [0.80-1.61],0.481103109923096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN2,Nectin-2,Inverse variance weighted,8,1.06 [0.77-1.47],0.721341713337104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE4,Ribonuclease 4,Inverse variance weighted,13,0.89 [0.73-1.09],0.270053037748981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AOC3,Membrane primary amine oxidase,Inverse variance weighted,36,0.95 [0.85-1.06],0.372035991605784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,13,1.10 [1.01-1.19],0.0363161693683761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,17,1.09 [0.90-1.31],0.379332013665794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,0.89 [0.64-1.24],0.490297854512271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,74,0.93 [0.88-0.99],0.025585090574219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,36,0.92 [0.83-1.03],0.137114719904847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,24,0.91 [0.76-1.09],0.287253926067276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.09 [0.84-1.41],0.516054182958563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,29,0.89 [0.78-1.01],0.0619833196004535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ULBP2,UL16-binding protein 2,Inverse variance weighted,37,0.97 [0.89-1.06],0.54361688163936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,23,1.02 [0.84-1.24],0.859151869414855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC13,Mucin-13,Inverse variance weighted,13,0.80 [0.62-1.02],0.0674016145159046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,11,1.06 [0.83-1.35],0.660194069559645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,15,0.79 [0.60-1.03],0.0858184589372973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADA2,Adenosine deaminase 2,Inverse variance weighted,18,1.14 [0.93-1.41],0.210226558086586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA5,Annexin A5,Inverse variance weighted,2,1.76 [0.78-3.95],0.173899927617265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,1.08 [0.82-1.43],0.587080919749072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WNT9A,Protein Wnt-9a,Inverse variance weighted,7,0.62 [0.38-1.04],0.0684564922723854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,1.11 [0.77-1.61],0.560931209060709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,31,1.01 [0.88-1.17],0.833405468720505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGRN,Agrin,Inverse variance weighted,31,1.05 [0.86-1.27],0.650672164502282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGA,Chromogranin-A,Inverse variance weighted,8,1.10 [0.84-1.44],0.49940945895679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.20 [0.80-1.78],0.379669945747489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.72 [0.40-1.28],0.261125475831693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF23,Fibroblast growth factor 23,Inverse variance weighted,17,1.08 [0.76-1.53],0.666141778882436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3C,Protein FAM3C,Inverse variance weighted,5,0.99 [0.54-1.80],0.970793602049575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,11,1.27 [0.88-1.81],0.199697383004164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.77 [0.54-1.09],0.135706268290849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.71 [0.55-0.91],0.008310027689937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,12,1.07 [0.84-1.37],0.576069304382837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,15,0.84 [0.65-1.08],0.175212460048206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,15,1.03 [0.86-1.23],0.740425338838824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,6,1.01 [0.58-1.74],0.982775960675507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,54,1.04 [0.94-1.16],0.461734769364496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNB2,Plexin-B2,Inverse variance weighted,37,0.93 [0.86-1.00],0.0513743676165201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,5,1.16 [0.69-1.94],0.582293917434735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,18,0.99 [0.83-1.17],0.872709531059969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,31,1.10 [0.81-1.48],0.550751556034814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.99 [0.80-1.23],0.946473507375233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,25,1.07 [0.91-1.27],0.409201485140248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN5,CCN family member 5,Inverse variance weighted,12,0.98 [0.78-1.22],0.847303325739716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REN,Renin,Inverse variance weighted,12,1.32 [1.07-1.64],0.0109809410935982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1A,Lithostathine-1-alpha,Inverse variance weighted,26,1.16 [1.00-1.35],0.0499810116468618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.71 [0.38-1.31],0.275063864104692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,12,1.19 [0.92-1.54],0.178576610550747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300E,CMRF35-like molecule 2,Inverse variance weighted,36,0.95 [0.83-1.09],0.491229792751967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMBP,Protein AMBP,Inverse variance weighted,5,0.85 [0.47-1.54],0.58397542195824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA1,Ephrin-A1,Inverse variance weighted,15,0.75 [0.63-0.90],0.0016583037432424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNCG,Gamma-synuclein,Inverse variance weighted,49,0.98 [0.87-1.09],0.69130153458418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD276,CD276 antigen,Inverse variance weighted,47,0.97 [0.88-1.07],0.490314216820106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.05 [0.95-1.17],0.327565004058298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,23,0.84 [0.68-1.04],0.115696457741674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP2,Retinol-binding protein 2,Inverse variance weighted,6,1.23 [0.72-2.12],0.44850026170769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,5,0.73 [0.47-1.15],0.173516321847441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,2,0.62 [0.35-1.12],0.113793858499133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,19,1.03 [0.83-1.27],0.81576922001942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK4,Kallikrein-4,Inverse variance weighted,20,1.06 [0.92-1.22],0.391963883512161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,18,0.93 [0.76-1.14],0.496549391832058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.32 [0.74-2.36],0.351049300128584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,20,1.02 [0.88-1.18],0.783907425905855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,40,0.99 [0.87-1.12],0.879751713420836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.18 [0.90-1.54],0.233387563084538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,9,1.30 [0.89-1.89],0.175247974909661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD46,Membrane cofactor protein,Inverse variance weighted,3,1.88 [1.09-3.24],0.0235309507721914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF5,Fibroblast growth factor 5,Inverse variance weighted,43,1.01 [0.91-1.12],0.864563315493548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,10,0.93 [0.77-1.14],0.504552425677096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,61,1.01 [0.94-1.08],0.887416037510947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD59,CD59 glycoprotein,Inverse variance weighted,8,1.05 [0.73-1.50],0.799373516143009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.84 [0.36-1.95],0.677713439589432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,10,1.18 [0.72-1.95],0.515549289578026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STC1,Stanniocalcin-1,Inverse variance weighted,11,0.96 [0.66-1.38],0.805848741544841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,19,1.02 [0.86-1.20],0.853776043363746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCG2,Secretogranin-2,Inverse variance weighted,3,1.30 [0.45-3.77],0.631265435162201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTN4R,Reticulon-4 receptor,Inverse variance weighted,26,0.86 [0.71-1.04],0.1174202506011
